×
About 18,050 results

ALLMedicine™ Vitamin K Center

Research & Reviews  8,437 results

Elective cardioversion of atrial fibrillation is safe without transesophageal echocardi...
https://doi.org/10.5603/CJ.a2021.0010
Cardiology Journal; Gorczyca I, Uziębło-Życzkowska B et. al.

Feb 26th, 2021 - Current guidelines recommend electrical cardioversion (ECV) in patients with atrial fibrillation (AF) after at least 3 weeks of adequate non-vitamin K antagonist oral anticoagulant (NOAC) treatment without prior transesophageal echocardiography (T...

New Avenues for Optimal Treatment of Atrial Fibrillation and Stroke Prevention.
https://doi.org/10.1161/STROKEAHA.120.032060
Stroke De Marchis GM, Sposato LA et. al.

Feb 25th, 2021 - One in 3 individuals free of atrial fibrillation (AF) at index age 55 years is estimated to develop AF later in life. AF increases not only the risk of ischemic stroke but also of dementia, even in stroke-free patients. In this review, we address ...

Reduced Vitamin K Status and Coronavirus Disease 2019: An Epiphenomenon of Impaired Kid...
https://doi.org/10.1093/cid/ciab164
Clinical Infectious Diseases : an Official Publication Of... Groothof D, Post A et. al.

Feb 25th, 2021 - Reduced Vitamin K Status and Coronavirus Disease 2019: An Epiphenomenon of Impaired Kidney Function?|2021|Groothof D,Post A,Gans ROB,Bakker SJL,|

Quality of life in patients with nonvalvular atrial fibrillation treated with oral anti...
https://doi.org/10.1080/16078454.2021.1892329
Hematology (Amsterdam, Netherlands); Gabilondo M, Loza J et. al.

Feb 25th, 2021 - Health-related quality of life (HRQL) is a key factor in making anticoagulant treatment decisions. The objective of this study was to assess the HRQL of patients with nonvalvular atrial fibrillation by treatment type: direct oral anticoagulants (D...

The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884179
Disease Markers; Xu F, Zhang L et. al.

Feb 25th, 2021 - At present, the diagnostic accuracy of alpha-fetoprotein (AFP) for hepatocellular carcinoma (HCC) surveillance is insufficient. It remains controversial whether prothrombin induced by vitamin K absence II (PIVKA-II) has a better diagnostic value t...

see more →

Guidelines  55 results

Anticoagulation: Updated Guidelines for Outpatient Management
https://www.aafp.org/afp/2019/1001/p426.html
American Family Physician;

Sep 30th, 2019 - Anticoagulation therapy is recommended for preventing, treating, and reducing the recurrence of venous thromboembolism, and preventing stroke in persons with atrial fibrillation. Direct oral anticoagulants are first-line agents for eligible patien...

Association Among Dietary Supplement Use, Nutrient Intake, and Mortality Among U.S. Adults
https://annals.org/aim/article-abstract/2730525/association-among-dietary-supplement-use-nutrient-intake-mortality-among-u
Chen,F.,et al

Apr 8th, 2019 - Background: The health benefits and risks of dietary supplement use are controversial. Objective: To evaluate the association among dietary supplement use, levels of nutrient intake from foods and supplements, and mortality among U.S. adults. De...

2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Managemen...
https://doi.org/10.1016/j.cjca.2018.08.026
The Canadian Journal of Cardiology; Andrade JG, Verma A et. al.

Nov 8th, 2018 - The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in atrial fibrillation (AF) management. This 2018 Focuse...

THE USE OF VITAMINS AND MINERALS IN SKELETAL HEALTH: AMERICAN ASSOCIATION OF CLINICAL E...
https://doi.org/10.4158/PS-2018-0050
Endocrine Practice : Official Journal of the American Col... Hurley DL, Binkley N et. al.

Jul 23rd, 2018 - 25(OH)D = 25-hydroxyvitamin D; BMD = bone mineral density; CV = cardiovascular; GI = gastrointestinal; IOM = Institute of Medicine; PTH = parathyroid hormone; RCT = randomized controlled trial; αTF = α-tocopherol; ucOC = undercarboxylated osteocal...

State of play and future direction with NOACs: An expert consensus.
https://doi.org/10.1016/j.vph.2018.04.001
Vascular Pharmacology; Cohen AT, Lip GY et. al.

Apr 15th, 2018 - Atrial fibrillation (AF) and venous thromboembolism (VTE) are cardiovascular conditions significant in contemporary practice. In both, the use of anticoagulation with vitamin K antagonists (VKAs) has been traditionally used to prevent adverse even...

see more →

Drugs  103 results see all →

Clinicaltrials.gov  8,937 results

Elective cardioversion of atrial fibrillation is safe without transesophageal echocardi...
https://doi.org/10.5603/CJ.a2021.0010
Cardiology Journal; Gorczyca I, Uziębło-Życzkowska B et. al.

Feb 26th, 2021 - Current guidelines recommend electrical cardioversion (ECV) in patients with atrial fibrillation (AF) after at least 3 weeks of adequate non-vitamin K antagonist oral anticoagulant (NOAC) treatment without prior transesophageal echocardiography (T...

New Avenues for Optimal Treatment of Atrial Fibrillation and Stroke Prevention.
https://doi.org/10.1161/STROKEAHA.120.032060
Stroke De Marchis GM, Sposato LA et. al.

Feb 25th, 2021 - One in 3 individuals free of atrial fibrillation (AF) at index age 55 years is estimated to develop AF later in life. AF increases not only the risk of ischemic stroke but also of dementia, even in stroke-free patients. In this review, we address ...

Reduced Vitamin K Status and Coronavirus Disease 2019: An Epiphenomenon of Impaired Kid...
https://doi.org/10.1093/cid/ciab164
Clinical Infectious Diseases : an Official Publication Of... Groothof D, Post A et. al.

Feb 25th, 2021 - Reduced Vitamin K Status and Coronavirus Disease 2019: An Epiphenomenon of Impaired Kidney Function?|2021|Groothof D,Post A,Gans ROB,Bakker SJL,|

Quality of life in patients with nonvalvular atrial fibrillation treated with oral anti...
https://doi.org/10.1080/16078454.2021.1892329
Hematology (Amsterdam, Netherlands); Gabilondo M, Loza J et. al.

Feb 25th, 2021 - Health-related quality of life (HRQL) is a key factor in making anticoagulant treatment decisions. The objective of this study was to assess the HRQL of patients with nonvalvular atrial fibrillation by treatment type: direct oral anticoagulants (D...

The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884179
Disease Markers; Xu F, Zhang L et. al.

Feb 25th, 2021 - At present, the diagnostic accuracy of alpha-fetoprotein (AFP) for hepatocellular carcinoma (HCC) surveillance is insufficient. It remains controversial whether prothrombin induced by vitamin K absence II (PIVKA-II) has a better diagnostic value t...

see more →

News  515 results

DOACs Look Safe in Elective Endoscopic Procedures
https://www.medscape.com/viewarticle/943566

Jan 4th, 2021 - Among patients taking direct oral anticoagulants (DOACs), elective endoscopy procedures carry a risk of bleeding and thromboembolic events similar to that seen in those receiving vitamin K antagonists (VKAs), according to a multicenter, prospectiv...

INR Correction in VKA-related Major Bleeding Linked to Better Survival
https://www.medscape.com/viewarticle/941681

Nov 26th, 2020 - Takeaway Uncorrected international normalised ratio (INR) is an important risk factor for mortality in vitamin K antagonist (VKA)-associated major bleeding for both intracranial haemorrhage (ICH) and non-ICH patients. Higher doses of vitamin K are...

Warfarin Use Linked to Knee and Hip Replacement in Osteoarthritis Patients
https://www.staging.medscape.com/viewarticle/940569

Nov 7th, 2020 - Patients who take the vitamin K antagonist warfarin to prevent thromboembolic events are significantly more likely to require knee or hip replacement surgery — a surrogate endpoint for end-stage osteoarthritis — than are patients who take direct o...

Warfarin Use Linked to Knee and Hip Replacement in Osteoarthritis Patients
https://www.medscape.com/viewarticle/940569

Nov 7th, 2020 - Patients who take the vitamin K antagonist warfarin to prevent thromboembolic events are significantly more likely to require knee or hip replacement surgery — a surrogate endpoint for end-stage osteoarthritis — than are patients who take direct o...

Venous Thromboembolism Clinical Practice Guidelines (ASH, 2020)
https://reference.staging.medscape.com/viewarticle/940033

Oct 29th, 2020 - The American Society of Hematology (ASH) released their updated recommendations on the management of venous thromboembolism (VTE) (deep vein thrombosis [DVT] and pulmonary embolism [PE]) in October 2020.[1] Select recommendations are outlined belo...

see more →

Patient Education  3 results see all →